Universitätsklinikum Hamburg-Eppendorf

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Subsidiary

Established: 1989-05-19

Employees: 1K

Market Cap: -

Website: http://www.uke.de

Clinical Trials

Enhancement of Motor Function with Reboxetine and Transcranial Direct Current Stimulation

Phase 4

Completed

Conditions: Cerebral Stroke

Interventions: Drug: Placebo
Drug: reboxetine
Device: tDCS sham
Device: tDCS verum

First Posted Date: 2009-03-02

Last Posted Date: 2024-12-10

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 12

Registration Number: NCT00853866

Locations: 🇩🇪
University Hospital Hamburg-Eppendorf, Department of Neurology, Hamburg, HH, Germany

Economisation of Whipple Resection Using Electrosurgical Sealing Device

Completed

Conditions: Duodenopancreatectomy

First Posted Date: 2009-02-24

Last Posted Date: 2017-06-23

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 89

Registration Number: NCT00850291

Locations: 🇩🇪
UH Eppendorf, Hamburg, Germany

Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment

Phase 4

Completed

Conditions: Chronic Hepatitis C
Intravenous Drug Abuse

Interventions: Behavioral: Psychoeducation

First Posted Date: 2009-02-16

Last Posted Date: 2015-05-28

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 189

Registration Number: NCT00844272

Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years

Phase 1

Completed

Conditions: Acute Myeloid Leukemia

First Posted Date: 2008-11-02

Last Posted Date: 2020-02-25

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 22

Registration Number: NCT00783653

Locations: 🇩🇪
PD Dr. med. Jürgen Krauter, Hannover, Germany
🇩🇪
Prof. Dr. med. Walter Fiedler, Hamburg, Germany
🇩🇪
Dr. Richard Schlenk, Ulm, Germany

and more 2 locations

Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma
Stem Cell Transplantation

First Posted Date: 2008-10-28

Last Posted Date: 2009-05-28

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 20

Registration Number: NCT00781170

Dose-finding of Lenalidomide as Maintenance in Multiple Myeloma

Phase 1

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Revlimid (Lenalidomide)

First Posted Date: 2008-10-23

Last Posted Date: 2015-05-13

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 24

Registration Number: NCT00778752

Locations: 🇩🇪
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
🇩🇪
Universitätsklinikum Heidelberg, Heidelberg, Germany

Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Procedure: auto-auto Tandem stem cell transplantation and maintenance therapy with Thalidomide
Procedure: Auto-Allo Tandem SCT and maintenance therapy with Thalidomide/ DLI

First Posted Date: 2008-10-23

Last Posted Date: 2023-10-27

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 221

Registration Number: NCT00777998

Locations: 🇩🇪
Deutsche Klinik für Diagnostik, Wiesbaden, Germany
🇩🇪
Universitätsklinikum Dresden, Dresden, Germany
🇩🇪
Charité, Berlin, Germany

and more 17 locations

Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL)

Phase 2

Completed

Conditions: Acute Lymphoblastic Leukemia

Interventions: Procedure: Hematopoietic stem cell transplantation

First Posted Date: 2008-05-22

Last Posted Date: 2015-05-13

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 50

Registration Number: NCT00682305

Locations: 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia

Phase 3

Completed

Conditions: Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia

Interventions: Drug: ATG FRESENIUS (Anti-Lymphocyte-Globulin)

First Posted Date: 2008-05-15

Last Posted Date: 2015-05-13

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 161

Registration Number: NCT00678275

Locations: 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients

Phase 2

Completed

Conditions: Myelofibrosis

Interventions: Procedure: Allogeneic Stem Cell Transplantation

First Posted Date: 2008-01-23

Last Posted Date: 2016-01-14

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 106

Registration Number: NCT00599547

Locations: 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy